VBBV-DARK SPOT

Manufacturer
Jiashen International Trading Co., Ltd.
Effective date
2024-11-20
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:38:16

Label at a glance#

ProductVBBV-DARK SPOT
Active ingredientHYALURONIC ACID, NIACINAMIDE, TOCOPHEROL, ASCORBIC ACID, RETINOL
Label structure11 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

ACTIVE INGREDIENT :

HYDROLYZED HYALURONIC ACID
RETINOL
NIACINAMIDE
ASCORBIC ACID
TOCOPHEROL

INACTIVE INGREDIENT SECTION

AQUA
SUNFLOWER OIL DECYL ESTERS
PANTOTHENIC ACID
TRIDECETH-6
ALOE VERA EXTRACT
HYDROLYZED OAT PROTEIN
GLYCYRRHIZA GLABRA EXTRACT
MORUS ALBA ROOT EXTRACT
2-o-ETHYL ASCORBIC ACID
HYDROXYPROLINE
PROLINE
CITRIC ACID

OTC - PURPOSE SECTION

.Desalination dark spot.Brightens and evensskin tone
.Improve skin elasticityand firmness
.Deeply hydrates andreduces the appear-ance of wrinkles andfine lines

WARNINGS SECTION

WARNINGS:
For external use only.Before using, test forsensitivity on a smallarea of skin. Please donot use it on damagedskin. Avoid contact witheyes. if contact occursrinse with clean runningwater.

OTC - STOP USE SECTION

If pregnant or breast-feading, ask a healthprofessional before use. Keep out of reach ofchildren. in case of overdose,got medical helpor contact a Poison Control Center right away.

OTC - DO NOT USE SECTION

Ask a doctor before use if you haveSkin sensitization.
Skin plastic surgery

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach ofchildren. In case of overdose,got medical helpor contact a Poison Control Center right away.

INDICATIONS & USAGE SECTION

Uses
neven skin tone
Spot removal for desired area

OTC - WHEN USING SECTION

When using this product
Swipe onto a clean face, moming and'or evening
Do not rinse.
For daytime use, follow with sunscreen

DOSAGE & ADMINISTRATION SECTION

It can be applied twicedaily(morning & night)and applied to cleansed& toned skin
Step 1: Wash your faceas usual.Step 2: Apply Dark SpotCorrector evenly todesired areas of theface.
Step 3: Gently kneadthe cream of thedesired area until theskin is fully absorbed

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

package labelingpackage labeling

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ASCORBIC ACID Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c5cd4727-ac49-4409-82b1-5bd8006c3ec7Product name120171122
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84867-008-01VBBV-DARK SPOT50 mL in 1 BOTTLE, GLASSLOTION501

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
84867-008VBBV-DARK SPOT LOTION [JIASHEN INTERNATIONAL TRADING CO., LTD.]11 package rows20241122_275af79b-50c7-ffec-e063-6394a90a4270.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84867-00884867-008-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
275af79b-50c8-ffec-e063-6394a90a4270275af79b-50c7-ffec-e063-6394a90a42702024-11-20WarningsExact identifier
spl id: 275af79b-50c8-ffec-e063-6394a90a4270
spl set id: 275af79b-50c7-ffec-e063-6394a90a4270

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.